Safety and Tolerability of Quetiapine in Multiple Sclerosis
Clinical trial NCT02087631 · COMPLETED
Trial details
- NCT number
- NCT02087631
- Sponsor
- University of Calgary
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2019-07-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.